American Pancreatic Association, December 2023 – Poster presentation “SAFE-D Trial design: Targeted pancreatic cancer screening to evaluate stage and resectability rate shift in patients with new-onset diabetes.”
American Diabetes Association 83rd Scientific Sessions, June 2023 – Poster presentation entitled “Implementation of the Avantect Pancreatic Cancer Test in Newly Diagnosed Type 2 Diabetes Patients in a Clinical Setting.” Meet Us At ADA Booth #1814 ClearNote...
Society for Laboratory Automation and Screening, May 2023 – Oral presentation “Automation of an Early Detection Pancreatic Cancer Test Using 5-Hydroxymethylation Profiles.”
American Association for Cancer Research, April 2023 – Poster presentation “Evaluation of the Avantect Pancreatic Cancer Test for Identifying High-Risk Pancreatic Cysts.”
American Society of Clinical Oncology, Gastrointestinal, January 2023 – Poster presentation “Early detection of pancreatic cancer using 5-hydroxymethylation profiles in plasma-derived cell-free DNA.”
Company unveils Avantect early cancer detection test portfolio SAN DIEGO—January 09, 2023—ClearNote Health™ (formerly known as Bluestar Genomics), a cancer detection company focused on enabling people at risk for high-mortality cancers to live longer healthier lives,...
